Test Bank Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th E By Woo
d d d d d d d d d d d
Pharmacotherapeutics for Advanced Practice Nurse d d d d
Prescribers 5th Edition Woo Robinson Test Bank
d d d d d d d
Chapter 1. The Role of the Nurse Practitioner as
d d d d d d d d
Prescriber Chapter 2. Review of the Basic Principles of
d d d d d d d d d
Pharmacology Chapter 3. Rational Drug Selection
d d d d d d
Chapter 4. Legal and Professional Issues in Prescribing
d d d d d d d
Chapter 5. Adverse Drug Reactions
d d d d d
Chapter 6. Pharmacogenetics
d d
Chapter 7. Nutrition and Neutraceuticals
d d d d
Chapter 8. Herbal Therapies and Cannabis
d d d d d d
Chapter 9. Informatics
d d d
Chapter 10. Pharmacoeconomics
d d
Chapter 11. Drugs Affecting the Autonomic Nervous System
d d d d d d d
Chapter 12. Drugs Affecting the Central Nervous System
d d d d d d d d
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems
d d d d d d d d
Chapter 14. Drugs Affecting the Respiratory System
d d d d d d d
Chapter 15. Drugs Affecting the Hematological System
d d d d d d
Chapter 16. Drugs Affecting the Immune System
d d d d d d d
Chapter 17. Drugs Affecting the Gastrointestinal System
d d d d d d d
Chapter 18. Drugs Affecting the Endocrine System: Pancreatic Hormones and
d d d d d d d d d
Antidiabetic Drugs
d d
Chapter 19. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and
d d d d d d d d d
Adrenal Drugs
d d
Chapter 20. Drugs Affecting the Reproductive System
d d d d d d
Chapter 21. Drugs Affecting the Bones and Joints
d d d d d d d d
Chapter 22. Drugs Affecting the Integumentary System
d d d d d d d
Chapter 23. Drugs Used to Treat Bacterial Infections
d d d d d d d d
Chapter 24. Drugs Used to Treat Viral, Fungal, and Protozoal Infections
d d d d d d d d d d
Chapter 25. Drugs Used to Treat Inflammatory Processes
d d d d d d d d
Chapter 26. Drugs Used to Treat Eye and Ear Disorders
d d d d d d d d d
Chapter 27. Alcohol and Drug Addiction
d d d d d d
Chapter 28. Anemia
d d
Chapter 29. Angina
d d
Chapter 30. Anxiety and Depression
d d d d
Chapter 31. Attention Deficit Hyperactivity Disorder
d d d d d
Chapter 32. Asthma and Chronic Obstructive Pulmonary Disease
d d d d d d d
Chapter 33. Contraception
d d d
Chapter 34. Dermatological Conditions
d d d
Chapter 35. Diabetes Management
d d d d
Chapter 36. Gastroesophageal Reflux and Peptic Ulcer Disease
d d d d d d d
Chapter 37. Headaches
d d d
Chapter 38. Heart Failure
d d d
Chapter 39. Human Immunodeficiency Virus Disease and Acquired Immunodeficiency
d d d d d d d d
Syndrome
d
Chapter 40. Hormone Replacement Therapy
d d d d
Chapter 41. Hyperlipidemia
d d d
Chapter 42. Hypertension
d d
Chapter 43. Hyperthyroidism and Hypothyroidism
d d d d
Chapter 44. Pain Management: Acute and Chronic Pain
d d d d d d d d
Chapter 45. Pneumonia
d d d
Chapter 46. Smoking Cessation
d d d
Chapter 47. Sexually Transmitted Diseases and Vaginitis
d d d d d d
Chapter 48. Tuberculosis
d d d
Chapter 49. Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis
d d d d d d d d d d
Externa
d
Chapter 50. Urinary Tract Infection
d d d d
Chapter 51. Women as Patients
d d d d d
Chapter 52. Men as Patients
d d d d d
Chapter 53. Pediatric Patients
d d d d
Chapter 54. Transgendered Clients as Patients
d d d d d
,Chapter 55. Geriatric Patients
d d d
Chapter 1. The Role of the Nurse Practitioner
d d d d d d d
Multiple Choice
d d
Identify the choice that best completes the statement or answers the question.
d d d d d d d d d d d
1. Nurse practitioner prescriptive authority is regulated by:
d d d d d d
1. The National Council of State Boards of Nursing
d d d d d d d
2. The U.S. Drug Enforcement Administration
d d d d
3. The State Board of Nursing for each state
d d d d d d d
4. The State Board of Pharmacy d d d d
2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber
d d d d d d d d d d d d d
include:d
1. Nurses know more about Pharmacology than other prescribers because they take it
d d d d d d d d d d d
both in their basic nursing program and in their APRN program.
d d d d d d d d d d d
2. Nurses care for the patient from a holistic approach and include the patient in
d d d d d d d d d d d d d
decision making regarding their care.
d d d d d
3. APRNs are less likely to prescribe narcotics and other controlled substances.
d d d d d d d d d d
4. APRNs are able to prescribe independently in all states, whereas a physician’s
d d d d d d d d d d d
assistant needs to have a physician supervising their practice.
d d d d d d d d d
3. Clinical judgment in prescribing includes:
d d d d
1. Factoring in the cost to the patient of the medication prescribed
d d d d d d d d d d
2. Always prescribing the newest medication available for the disease process
d d d d d d d d d
3. Handing out drug samples to poor patients d d d d d d
4. Prescribing all generic medications to cut costs d d d d d d
4. Criteria for choosing an effective drug for a disorder include:
d d d d d d d d d
1. Asking the patient what drug they think would work best for them
d d d d d d d d d d d
2. Consulting nationally recognized guidelines for disease management d d d d d d
3. Prescribing medications that are available as samples before writing a prescription
d d d d d d d d d d
4. Following U.S. Drug Enforcement Administration guidelines for prescribing
d d d d d d d
5. Nurse practitioner practice may thrive under health-care reform because of:
d d d d d d d d d
1. The demonstrated ability of nurse practitioners to control costs and improve patient
d d d d d d d d d d d
outcomes d
2. The fact that nurse practitioners will be able to practice independently
d d d d d d d d d d
3. The fact that nurse practitioners will have full reimbursement under health-care
d d d d d d d d d d
reform d
4. The ability to shift accountability for Medicaid to the state level
d d d d d d d d d d
,Chapter 1. The Role of the Nurse Practitioner
d d d d d d d
Answer Section
d d
MULTIPLE CHOICE d
1. ANS: d d 3 PTS: d 1
2. ANS: d d 2 PTS: d 1
3. ANS: d d 1 PTS: d 1
4. ANS: d d 2 PTS: d 1
5. ANS: d d 1 PTS: d 1
Chapter 2. Review of Basic Principles of Pharmacology
d d d d d d d
d Multiple Choice d
Identify the choice that best completes the statement or answers the question.
d d d d d d d d d d d
d 1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical to
d d d d d d d d d d d d d
prescribing because:
d d
1. Distribution of drugs to target tissue may be affected. d d d d d d d d
2. The solubility of the drug will not match the site of absorption.
d d d d d d d d d d d
3. There will be less free drug available to generate an effect.
d d d d d d d d d d
4. Drugs bound to albumin are readily excreted by the kidneys.
d d d d d d d d d
d 2. Drugs that have a significant first-pass effect:
d d d d d d d
1. Must be given by the enteral (oral) route onlyd d d d d d d d
2. Bypass the hepatic circulation d d d
3. Are rapidly metabolized by the liver and may have little if any desired action
d d d d d d d d d d d d d
4. Are converted by the liver to more active and fat-soluble forms
d d d d d d d d d d
d d 3. The route of excretion of a volatile drug will likely be the:
d d d d d d d d d d d d
1. Kidneys
2. Lungs
3. Bile and feces d d
4. Skin
d 4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a storage
d d d d d d d d d d d
reservoir of the drug. Storage reservoirs:
d d d d d d
1. Assure that the drug will reach its intended target tissue d d d d d d d d d
2. Are the reason for giving loading doses d d d d d d
3. Increase the length of time a drug is available and active d d d d d d d d d d
4. Are most common in collagen tissues d d d d d
d d 5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
d d d d d d d d d d d d d d d
1. Propensity to go to the target receptor d d d d d d
2. Biological half-life d
3. Pharmacodynamics
4. Safety and side effects d d d
, d 6. Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the
d d d d d d d d d d d d d d d d d d
prescription. This is considered a loading dose. A loading dose:
d d d d d d d d d d
1. Rapidly achieves drug levels in the therapeutic range d d d d d d d
2. Requires four- to five-half-lives to attain d d d d d
3. Is influenced by renal function
d d d d
4. Is directly related to the drug circulating to the target tissues
d d d d d d d d d d
d 7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic effect
d d d d d d d d d d d d d d d d d d
is the:
d d
1. Minimum adverse effect level d d d
2. Peak of action d d
3. Onset of action d d
4. Therapeutic range d
d d 8. Phenytoin requires that a trough level be drawn. Peak and trough levels are done:
d d d d d d d d d d d d d d
1. When the drug has a wide therapeutic range d d d d d d d
2. When the drug will be administered for a short time only
d d d d d d d d d d
3. When there is a high correlation between the dose and saturation of receptor sites
d d d d d d d d d d d d d
4. To determine if a drug is in the therapeutic range
d d d d d d d d d
d d 9. A laboratory result indicates that the peak level for a drug is above the minimum toxic concentration.
d d d d d d d d d d d d d d d d d
This means that the:
d d d
1. Concentration will produce therapeutic effects d d d d
2. Concentration will produce an adverse response d d d d d
3. Time between doses must be shortened d d d d d
4. Duration of action of the drug is too long d d d d d d d d
d 10. Drugs that are receptor agonists may demonstrate what property?
d d d d d d d d d
1. Irreversible binding to the drug receptor site d d d d d d
2. Upregulation with chronic use d d d
3. Desensitization or downregulation with continuous use d d d d d
4. Inverse relationship between drug concentration and drug action
d d d d d d d
d 11. Drugs that are receptor antagonists, such as beta blockers, may cause:
d d d d d d d d d d d
1. Downregulation of the drug receptor d d d d
2. An exaggerated response if abruptly discontinued
d d d d d
3. Partial blockade of the effects of agonist drugs d d d d d d d
4. An exaggerated response to competitive drug agonists
d d d d d d
d 12. Factors that affect gastric drug absorption include:
d d d d d d d
1. Liver enzyme activity d d
2. Protein-binding properties of the drug molecule d d d d d
3. Lipid solubility of the drug d d d d
4. Ability to chew and swallow d d d d
d 13. Drugs administered via IV:
d d d d
1. Need to be lipid soluble in order to be easily absorbed
d d d d d d d d d d
2. Begin distribution into the body immediately d d d d d
3. Are easily absorbed if they are nonionized
d d d d d d
4. May use pinocytosis to be absorbed d d d d d
d 14. When a medication is added to a regimen for a synergistic effect, the combined effect of the drugs is:
d d d d d d d d d d d d d d d d d d d
1. The sum of the effects of each drug individually
d d d d d d d d
d d d d d d d d d d d
Pharmacotherapeutics for Advanced Practice Nurse d d d d
Prescribers 5th Edition Woo Robinson Test Bank
d d d d d d d
Chapter 1. The Role of the Nurse Practitioner as
d d d d d d d d
Prescriber Chapter 2. Review of the Basic Principles of
d d d d d d d d d
Pharmacology Chapter 3. Rational Drug Selection
d d d d d d
Chapter 4. Legal and Professional Issues in Prescribing
d d d d d d d
Chapter 5. Adverse Drug Reactions
d d d d d
Chapter 6. Pharmacogenetics
d d
Chapter 7. Nutrition and Neutraceuticals
d d d d
Chapter 8. Herbal Therapies and Cannabis
d d d d d d
Chapter 9. Informatics
d d d
Chapter 10. Pharmacoeconomics
d d
Chapter 11. Drugs Affecting the Autonomic Nervous System
d d d d d d d
Chapter 12. Drugs Affecting the Central Nervous System
d d d d d d d d
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems
d d d d d d d d
Chapter 14. Drugs Affecting the Respiratory System
d d d d d d d
Chapter 15. Drugs Affecting the Hematological System
d d d d d d
Chapter 16. Drugs Affecting the Immune System
d d d d d d d
Chapter 17. Drugs Affecting the Gastrointestinal System
d d d d d d d
Chapter 18. Drugs Affecting the Endocrine System: Pancreatic Hormones and
d d d d d d d d d
Antidiabetic Drugs
d d
Chapter 19. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and
d d d d d d d d d
Adrenal Drugs
d d
Chapter 20. Drugs Affecting the Reproductive System
d d d d d d
Chapter 21. Drugs Affecting the Bones and Joints
d d d d d d d d
Chapter 22. Drugs Affecting the Integumentary System
d d d d d d d
Chapter 23. Drugs Used to Treat Bacterial Infections
d d d d d d d d
Chapter 24. Drugs Used to Treat Viral, Fungal, and Protozoal Infections
d d d d d d d d d d
Chapter 25. Drugs Used to Treat Inflammatory Processes
d d d d d d d d
Chapter 26. Drugs Used to Treat Eye and Ear Disorders
d d d d d d d d d
Chapter 27. Alcohol and Drug Addiction
d d d d d d
Chapter 28. Anemia
d d
Chapter 29. Angina
d d
Chapter 30. Anxiety and Depression
d d d d
Chapter 31. Attention Deficit Hyperactivity Disorder
d d d d d
Chapter 32. Asthma and Chronic Obstructive Pulmonary Disease
d d d d d d d
Chapter 33. Contraception
d d d
Chapter 34. Dermatological Conditions
d d d
Chapter 35. Diabetes Management
d d d d
Chapter 36. Gastroesophageal Reflux and Peptic Ulcer Disease
d d d d d d d
Chapter 37. Headaches
d d d
Chapter 38. Heart Failure
d d d
Chapter 39. Human Immunodeficiency Virus Disease and Acquired Immunodeficiency
d d d d d d d d
Syndrome
d
Chapter 40. Hormone Replacement Therapy
d d d d
Chapter 41. Hyperlipidemia
d d d
Chapter 42. Hypertension
d d
Chapter 43. Hyperthyroidism and Hypothyroidism
d d d d
Chapter 44. Pain Management: Acute and Chronic Pain
d d d d d d d d
Chapter 45. Pneumonia
d d d
Chapter 46. Smoking Cessation
d d d
Chapter 47. Sexually Transmitted Diseases and Vaginitis
d d d d d d
Chapter 48. Tuberculosis
d d d
Chapter 49. Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis
d d d d d d d d d d
Externa
d
Chapter 50. Urinary Tract Infection
d d d d
Chapter 51. Women as Patients
d d d d d
Chapter 52. Men as Patients
d d d d d
Chapter 53. Pediatric Patients
d d d d
Chapter 54. Transgendered Clients as Patients
d d d d d
,Chapter 55. Geriatric Patients
d d d
Chapter 1. The Role of the Nurse Practitioner
d d d d d d d
Multiple Choice
d d
Identify the choice that best completes the statement or answers the question.
d d d d d d d d d d d
1. Nurse practitioner prescriptive authority is regulated by:
d d d d d d
1. The National Council of State Boards of Nursing
d d d d d d d
2. The U.S. Drug Enforcement Administration
d d d d
3. The State Board of Nursing for each state
d d d d d d d
4. The State Board of Pharmacy d d d d
2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber
d d d d d d d d d d d d d
include:d
1. Nurses know more about Pharmacology than other prescribers because they take it
d d d d d d d d d d d
both in their basic nursing program and in their APRN program.
d d d d d d d d d d d
2. Nurses care for the patient from a holistic approach and include the patient in
d d d d d d d d d d d d d
decision making regarding their care.
d d d d d
3. APRNs are less likely to prescribe narcotics and other controlled substances.
d d d d d d d d d d
4. APRNs are able to prescribe independently in all states, whereas a physician’s
d d d d d d d d d d d
assistant needs to have a physician supervising their practice.
d d d d d d d d d
3. Clinical judgment in prescribing includes:
d d d d
1. Factoring in the cost to the patient of the medication prescribed
d d d d d d d d d d
2. Always prescribing the newest medication available for the disease process
d d d d d d d d d
3. Handing out drug samples to poor patients d d d d d d
4. Prescribing all generic medications to cut costs d d d d d d
4. Criteria for choosing an effective drug for a disorder include:
d d d d d d d d d
1. Asking the patient what drug they think would work best for them
d d d d d d d d d d d
2. Consulting nationally recognized guidelines for disease management d d d d d d
3. Prescribing medications that are available as samples before writing a prescription
d d d d d d d d d d
4. Following U.S. Drug Enforcement Administration guidelines for prescribing
d d d d d d d
5. Nurse practitioner practice may thrive under health-care reform because of:
d d d d d d d d d
1. The demonstrated ability of nurse practitioners to control costs and improve patient
d d d d d d d d d d d
outcomes d
2. The fact that nurse practitioners will be able to practice independently
d d d d d d d d d d
3. The fact that nurse practitioners will have full reimbursement under health-care
d d d d d d d d d d
reform d
4. The ability to shift accountability for Medicaid to the state level
d d d d d d d d d d
,Chapter 1. The Role of the Nurse Practitioner
d d d d d d d
Answer Section
d d
MULTIPLE CHOICE d
1. ANS: d d 3 PTS: d 1
2. ANS: d d 2 PTS: d 1
3. ANS: d d 1 PTS: d 1
4. ANS: d d 2 PTS: d 1
5. ANS: d d 1 PTS: d 1
Chapter 2. Review of Basic Principles of Pharmacology
d d d d d d d
d Multiple Choice d
Identify the choice that best completes the statement or answers the question.
d d d d d d d d d d d
d 1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical to
d d d d d d d d d d d d d
prescribing because:
d d
1. Distribution of drugs to target tissue may be affected. d d d d d d d d
2. The solubility of the drug will not match the site of absorption.
d d d d d d d d d d d
3. There will be less free drug available to generate an effect.
d d d d d d d d d d
4. Drugs bound to albumin are readily excreted by the kidneys.
d d d d d d d d d
d 2. Drugs that have a significant first-pass effect:
d d d d d d d
1. Must be given by the enteral (oral) route onlyd d d d d d d d
2. Bypass the hepatic circulation d d d
3. Are rapidly metabolized by the liver and may have little if any desired action
d d d d d d d d d d d d d
4. Are converted by the liver to more active and fat-soluble forms
d d d d d d d d d d
d d 3. The route of excretion of a volatile drug will likely be the:
d d d d d d d d d d d d
1. Kidneys
2. Lungs
3. Bile and feces d d
4. Skin
d 4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a storage
d d d d d d d d d d d
reservoir of the drug. Storage reservoirs:
d d d d d d
1. Assure that the drug will reach its intended target tissue d d d d d d d d d
2. Are the reason for giving loading doses d d d d d d
3. Increase the length of time a drug is available and active d d d d d d d d d d
4. Are most common in collagen tissues d d d d d
d d 5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
d d d d d d d d d d d d d d d
1. Propensity to go to the target receptor d d d d d d
2. Biological half-life d
3. Pharmacodynamics
4. Safety and side effects d d d
, d 6. Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the
d d d d d d d d d d d d d d d d d d
prescription. This is considered a loading dose. A loading dose:
d d d d d d d d d d
1. Rapidly achieves drug levels in the therapeutic range d d d d d d d
2. Requires four- to five-half-lives to attain d d d d d
3. Is influenced by renal function
d d d d
4. Is directly related to the drug circulating to the target tissues
d d d d d d d d d d
d 7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic effect
d d d d d d d d d d d d d d d d d d
is the:
d d
1. Minimum adverse effect level d d d
2. Peak of action d d
3. Onset of action d d
4. Therapeutic range d
d d 8. Phenytoin requires that a trough level be drawn. Peak and trough levels are done:
d d d d d d d d d d d d d d
1. When the drug has a wide therapeutic range d d d d d d d
2. When the drug will be administered for a short time only
d d d d d d d d d d
3. When there is a high correlation between the dose and saturation of receptor sites
d d d d d d d d d d d d d
4. To determine if a drug is in the therapeutic range
d d d d d d d d d
d d 9. A laboratory result indicates that the peak level for a drug is above the minimum toxic concentration.
d d d d d d d d d d d d d d d d d
This means that the:
d d d
1. Concentration will produce therapeutic effects d d d d
2. Concentration will produce an adverse response d d d d d
3. Time between doses must be shortened d d d d d
4. Duration of action of the drug is too long d d d d d d d d
d 10. Drugs that are receptor agonists may demonstrate what property?
d d d d d d d d d
1. Irreversible binding to the drug receptor site d d d d d d
2. Upregulation with chronic use d d d
3. Desensitization or downregulation with continuous use d d d d d
4. Inverse relationship between drug concentration and drug action
d d d d d d d
d 11. Drugs that are receptor antagonists, such as beta blockers, may cause:
d d d d d d d d d d d
1. Downregulation of the drug receptor d d d d
2. An exaggerated response if abruptly discontinued
d d d d d
3. Partial blockade of the effects of agonist drugs d d d d d d d
4. An exaggerated response to competitive drug agonists
d d d d d d
d 12. Factors that affect gastric drug absorption include:
d d d d d d d
1. Liver enzyme activity d d
2. Protein-binding properties of the drug molecule d d d d d
3. Lipid solubility of the drug d d d d
4. Ability to chew and swallow d d d d
d 13. Drugs administered via IV:
d d d d
1. Need to be lipid soluble in order to be easily absorbed
d d d d d d d d d d
2. Begin distribution into the body immediately d d d d d
3. Are easily absorbed if they are nonionized
d d d d d d
4. May use pinocytosis to be absorbed d d d d d
d 14. When a medication is added to a regimen for a synergistic effect, the combined effect of the drugs is:
d d d d d d d d d d d d d d d d d d d
1. The sum of the effects of each drug individually
d d d d d d d d
